Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
HR breast cancer patients
.
Show all posts
Showing posts with label
HR breast cancer patients
.
Show all posts
Tuesday, July 18, 2017
Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR breast cancer patients
›
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal wo...
›
Home
View web version
